{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:10:08Z","timestamp":1788999008786,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pancreatic ductal adenocarcinoma (PDAC) exhibits hyperactive mitochondrial metabolism, yet how this rewiring spatially restricts the availability of metabolites for oncogenic signaling and drives systemic metabolic dysregulation in PDAC remains unknown. Here, we identify enhanced mitochondrial \u03b1-ketoglutarate (\u03b1-KG) sequestration as a key metabolic vulnerability in PDAC. Using multi-omics, preclinical models, and clinical correlation analyses, we identified elevated mitochondrial metabolic gene expression in PDAC. Moreover, higher expression of dihydrolipoamide succinyltransferase (DLST) correlates with poorer PDAC prognosis, suggesting the role of mitochondrial \u03b1-KG sequestration in PDAC progression. Targeting mitochondrial respiration with the complex I inhibitor carboxyamidotriazole orotate (CTO) redirected \u03b1-KG flux from mitochondrial sequestration, and increased \u03b1-KG-dependent m6A demethylation of\n                    <jats:italic>MYC<\/jats:italic>\n                    mRNA and HIF-1\u03b1 hydroxylation. Combining CTO or \u03b1-KG dehydrogenase complex inhibitor devimistat with an \u03b1-KG analog (dimethyl \u03b1-KG) amplified c-Myc\/HIF-1\u03b1 suppression. Consequently, prolonged CTO exposure downregulated multiple metabolic pathways (glycolysis, pentose phosphate pathway, fatty acid synthesis) regulated by c-Myc\/HIF-1\u03b1, and significantly delayed PDAC progression in vitro and in vivo. Our work first identify a novel mechanism whereby mitochondrial metabolism drives systemic metabolic dysregulation in PDAC through the sequestration of \u03b1-KG, and establishes \u201credirecting \u03b1-KG flux from mitochondrial sequestration\u201d as a strategy to disable PDAC\u2019s metabolic adaptability. The orotate salt form of carboxyamidotriazole effectively disrupts mitochondrial \u03b1-KG sequestration to suppresses PDAC growth at a dose equivalent to the clinically tested level.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09016-1","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:25:10Z","timestamp":1782397510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting mitochondrial \u03b1-ketoglutarate sequestration disables dual oncogenic drivers and metabolic adaptability in pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6705-1111","authenticated-orcid":false,"given":"Yeting","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-6891","authenticated-orcid":false,"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4192-0529","authenticated-orcid":false,"given":"Jiaxing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5294-8870","authenticated-orcid":false,"given":"Rui","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9060-3988","authenticated-orcid":false,"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"9016_CR1","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-14-2425","volume":"21","author":"AC Kimmelman","year":"2015","unstructured":"Kimmelman AC. Metabolic dependencies in RAS-driven cancers. Clin Cancer Res : J Am Assoc Cancer Res. 2015;21:1828\u201334.","journal-title":"Clin Cancer Res : J Am Assoc Cancer Res"},{"key":"9016_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Si W, Xia L, Yin D, Wei T, Tao M, et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer. 2024;23:90.","journal-title":"Mol Cancer"},{"key":"9016_CR3","first-page":"861","volume":"12","author":"X Chang","year":"2022","unstructured":"Chang X, Liu X, Wang H, Yang X, Gu Y. Glycolysis in the progression of pancreatic cancer. Am J Cancer Res. 2022;12:861\u201372.","journal-title":"Am J Cancer Res"},{"key":"9016_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012;149:656\u201370.","journal-title":"Cell"},{"key":"9016_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013;496:101\u20135.","journal-title":"Nature"},{"key":"9016_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07472-8","volume":"9","author":"N Santana-Codina","year":"2018","unstructured":"Santana-Codina N, Roeth AA, Zhang Y, Yang A, Mashadova O, Asara JM, et al. Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. Nat Commun. 2018;9:4945.","journal-title":"Nat Commun"},{"key":"9016_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101966","volume":"6","author":"X Jiang","year":"2025","unstructured":"Jiang X, Wang T, Zhao B, Sun H, Dong Y, Ma Y, et al. KRAS(G12D)-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC. Cell Rep Med. 2025;6:101966.","journal-title":"Cell Rep Med"},{"key":"9016_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","volume":"5","author":"Y Dong","year":"2020","unstructured":"Dong Y, Tu R, Liu H, Qing G. Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat. Signal Transduct Target Ther. 2020;5:124.","journal-title":"Signal Transduct Target Ther"},{"key":"9016_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nature13611","volume":"514","author":"A Viale","year":"2014","unstructured":"Viale A, Pettazzoni P, Lyssiotis CA, Ying H, S\u00e1nchez N, Marchesini M, et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature. 2014;514:628\u201332.","journal-title":"Nature"},{"key":"9016_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108231","volume":"33","author":"KER Hollinshead","year":"2020","unstructured":"Hollinshead KER, Parker SJ, Eapen VV, Encarnacion-Rosado J, Sohn A, Oncu T, et al. Respiratory supercomplexes promote mitochondrial efficiency and growth in severely hypoxic pancreatic cancer. Cell Rep. 2020;33:108231.","journal-title":"Cell Rep"},{"key":"9016_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104483","volume":"25","author":"MM Islam","year":"2022","unstructured":"Islam MM, Goertzen A, Singh PK, Saha R. Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modeling. iScience. 2022;25:104483.","journal-title":"iScience"},{"key":"9016_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41580-022-00572-w","volume":"24","author":"SA Baker","year":"2023","unstructured":"Baker SA, Rutter J. Metabolites as signalling molecules. Nat Rev Mol cell Biol. 2023;24:355\u201374.","journal-title":"Nat Rev Mol cell Biol"},{"key":"9016_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11:102.","journal-title":"Nat Commun"},{"key":"9016_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.tibs.2022.03.008","volume":"47","author":"D Zhu","year":"2022","unstructured":"Zhu D, Li X, Tian Y. Mitochondrial-to-nuclear communication in aging: an epigenetic perspective. Trends Biochem Sci. 2022;47:645\u201359.","journal-title":"Trends Biochem Sci"},{"key":"9016_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.devcel.2020.06.036","volume":"54","author":"G Figlia","year":"2020","unstructured":"Figlia G, Willnow P, Teleman AA. Metabolites regulate cell signaling and growth via covalent modification of proteins. Dev Cell. 2020;54:156\u201370.","journal-title":"Dev Cell"},{"key":"9016_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11274-020-02900-8","volume":"36","author":"F Legendre","year":"2020","unstructured":"Legendre F, MacLean A, Appanna VP, Appanna VD. Biochemical pathways to \u03b1-ketoglutarate, a multi-faceted metabolite. World J Microbiol Biotechnol. 2020;36:123.","journal-title":"World J Microbiol Biotechnol"},{"key":"9016_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41586-019-1577-5","volume":"573","author":"Morris","year":"2019","unstructured":"Morris JPt, Yashinskie JJ, Koche R, Chandwani R, Tian S, et al. \u03b1-Ketoglutarate links p53 to cell fate during tumour suppression. Nature. 2019;573:595\u20139.","journal-title":"Nature"},{"key":"9016_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41421-023-00558-8","volume":"9","author":"X Ren","year":"2023","unstructured":"Ren X, Yan J, Zhao Q, Bao X, Han X, Zheng C, et al. The Fe-S cluster assembly protein IscU2 increases \u03b1-ketoglutarate catabolism and DNA 5mC to promote tumor growth. Cell Discov. 2023;9:76.","journal-title":"Cell Discov"},{"key":"9016_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41586-025-09097-6","volume":"643","author":"A Chaves-Perez","year":"2025","unstructured":"Chaves-Perez A, Millman SE, Janaki-Raman S, Ho YJ, Hinterleitner C, Barthet VJA, et al. Metabolic adaptations direct cell fate during tissue regeneration. Nature. 2025;643:468\u201377.","journal-title":"Nature"},{"key":"9016_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41419-021-03739-z","volume":"12","author":"X Yang","year":"2021","unstructured":"Yang X, Shao F, Guo D, Wang W, Wang J, Zhu R, et al. WNT\/\u03b2-catenin-suppressed FTO expression increases m(6)A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis. Cell Death Dis. 2021;12:462.","journal-title":"Cell Death Dis"},{"key":"9016_CR21","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.21037\/atm-21-4712","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li L, Ye Z, Zhang L, Yao N, Gai L. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma. Ann Transl Med. 2021;9:1554.","journal-title":"Ann Transl Med"},{"key":"9016_CR22","doi-asserted-by":"publisher","first-page":"24967","DOI":"10.18632\/aging.103767","volume":"12","author":"Z Yang","year":"2020","unstructured":"Yang Z, Jiang X, Li D, Jiang X. HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification. Aging. 2020;12:24967\u201382.","journal-title":"Aging"},{"key":"9016_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10685-w","volume":"23","author":"S Ma","year":"2023","unstructured":"Ma S, Chen Y, Quan P, Zhang J, Han S, Wang G, et al. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling. BMC cancer. 2023;23:280.","journal-title":"BMC cancer"},{"key":"9016_CR24","doi-asserted-by":"publisher","first-page":"e143729.","DOI":"10.1172\/JCI143729","volume":"131","author":"I Liikanen","year":"2021","unstructured":"Liikanen I, Lauhan C, Quon S, Omilusik K, Phan AT, Bartrol\u00ed LB, et al. Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells. J Clin Investig. 2021;131:e143729.","journal-title":"J Clin Investig"},{"key":"9016_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122890","volume":"352","author":"N Taneja","year":"2024","unstructured":"Taneja N, Chauhan A, Kulshreshtha R, Singh S. HIF-1 mediated metabolic reprogramming in cancer: mechanisms and therapeutic implications. Life Sci. 2024;352:122890.","journal-title":"Life Sci"},{"key":"9016_CR26","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","volume":"5","author":"ZE Stine","year":"2015","unstructured":"Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV. MYC, metabolism, and cancer. Cancer Discov. 2015;5:1024\u201339.","journal-title":"Cancer Discov"},{"key":"9016_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56894-8","volume":"16","author":"A Garc\u00eda Garc\u00eda","year":"2025","unstructured":"Garc\u00eda Garc\u00eda A, Ferrer Aporta M, Vallejo Palma G, Gir\u00e1ldez Trujillo A, Castillo-Gonz\u00e1lez R, Calz\u00f3n Lozano D, et al. Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity. Nat Commun. 2025;16:1694.","journal-title":"Nat Commun"},{"key":"9016_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41388-024-03174-2","volume":"44","author":"ST Jakobsen","year":"2025","unstructured":"Jakobsen ST, Siersb\u00e6k R. Transcriptional regulation by MYC: an emerging new model. Oncogene. 2025;44:1\u20137.","journal-title":"Oncogene"},{"key":"9016_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/bs.ircmb.2024.03.005","volume":"389","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee S, Prashanth P, Rawat V, Ghosh Roy S. Regulation of lipid and serine metabolism by the oncogene c-Myc. Int Rev cell Mol Biol. 2024;389:236\u201356.","journal-title":"Int Rev cell Mol Biol"},{"key":"9016_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.canlet.2015.10.025","volume":"370","author":"R Ju","year":"2016","unstructured":"Ju R, Guo L, Li J, Zhu L, Yu X, Chen C, et al. Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition. Cancer Lett. 2016;370:232\u201341.","journal-title":"Cancer Lett"},{"key":"9016_CR31","doi-asserted-by":"publisher","first-page":"e55845.","DOI":"10.7554\/eLife.55845","volume":"9","author":"ZA Stephenson","year":"2020","unstructured":"Stephenson ZA, Harvey RF, Pryde KR, Mistry S, Hardy RE, Serreli R, et al. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I. eLife. 2020;9:e55845.","journal-title":"eLife"},{"key":"9016_CR32","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1200\/JCO.2017.76.9992","volume":"36","author":"A Omuro","year":"2018","unstructured":"Omuro A, Beal K, McNeill K, Young RJ, Thomas A, Lin X, et al. Multicenter phase ib trial of carboxyamidotriazole orotate and temozolomide for recurrent and newly diagnosed glioblastoma and other anaplastic gliomas. J Clin Oncol : J Am Soc Clin Oncol. 2018;36:1702\u20139.","journal-title":"J Clin Oncol : J Am Soc Clin Oncol"},{"key":"9016_CR33","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic acids Res. 2017;45:W98\u2013102.","journal-title":"Nucleic acids Res"},{"key":"9016_CR34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1158\/0008-5472.CAN-10-1032","volume":"71","author":"X Wang","year":"2011","unstructured":"Wang X, Cunningham M, Zhang X, Tokarz S, Laraway B, Troxell M, et al. Phosphorylation regulates c-Myc\u2019s oncogenic activity in the mammary gland. Cancer Res. 2011;71:925\u201336.","journal-title":"Cancer Res"},{"key":"9016_CR35","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1158\/1541-7786.MCR-21-0560","volume":"20","author":"CJ Daniel","year":"2022","unstructured":"Daniel CJ, Pelz C, Wang X, Munks MW, Ko A, Murugan D, et al. T-cell dysfunction upon expression of MYC with altered phosphorylation at threonine 58 and serine 62. Mol Cancer Res. 2022;20:1151\u201365.","journal-title":"Mol Cancer Res"},{"key":"9016_CR36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ncb1110","volume":"6","author":"E Yeh","year":"2004","unstructured":"Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat cell Biol. 2004;6:308\u201318.","journal-title":"Nat cell Biol"},{"key":"9016_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ccell.2020.01.001","volume":"37","author":"J Jiang","year":"2020","unstructured":"Jiang J, Wang J, Yue M, Cai X, Wang T, Wu C, et al. Direct phosphorylation and stabilization of MYC by aurora B kinase promote T-cell leukemogenesis. Cancer cell. 2020;37:200\u201315.e5.","journal-title":"Cancer cell"},{"key":"9016_CR38","doi-asserted-by":"publisher","first-page":"9137.","DOI":"10.3390\/ijms23169137","volume":"23","author":"GS Chen","year":"2022","unstructured":"Chen GS, Chen SY, Liu ST, Hsieh CC, Lee SP, Huang SM. Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram\/Copper Complex in Oral Cancer Cells. Int J Mol Sci. 2022;23:9137.","journal-title":"Int J Mol Sci"},{"key":"9016_CR39","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41419-023-06226-9","volume":"14","author":"C Liu","year":"2023","unstructured":"Liu C, Rokavec M, Huang Z, Hermeking H. Salicylate induces AMPK and inhibits c-MYC to activate a NRF2\/ARE\/miR-34a\/b\/c cascade resulting in suppression of colorectal cancer metastasis. Cell Death Dis. 2023;14:707.","journal-title":"Cell Death Dis"},{"key":"9016_CR40","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.bbrc.2006.02.088","volume":"342","author":"C Treins","year":"2006","unstructured":"Treins C, Murdaca J, Van Obberghen E, Giorgetti-Peraldi S. AMPK activation inhibits the expression of HIF-1alpha induced by insulin and IGF-1. Biochem Biophys Res Commun. 2006;342:1197\u2013202.","journal-title":"Biochem Biophys Res Commun"},{"key":"9016_CR41","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1158\/1078-0432.CCR-24-3296","volume":"31","author":"APM Beerkens","year":"2025","unstructured":"Beerkens APM, Heskamp S, Reinema FV, Adema GJ, Span PN, Bussink J. Mitochondria targeting of oxidative phosphorylation inhibitors to alleviate hypoxia and enhance anticancer treatment efficacy. Clin Cancer Res : J Am Assoc Cancer Res. 2025;31:1186\u201393.","journal-title":"Clin Cancer Res : J Am Assoc Cancer Res"},{"key":"9016_CR42","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1182\/blood-2005-03-1138","volume":"106","author":"K Doege","year":"2005","unstructured":"Doege K, Heine S, Jensen I, Jelkmann W, Metzen E. Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood. 2005;106:2311\u20137.","journal-title":"Blood"},{"key":"9016_CR43","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med. 2018;24:1036\u201346.","journal-title":"Nat Med"},{"key":"9016_CR44","volume":"49","author":"DF Boreel","year":"2024","unstructured":"Boreel DF, Beerkens APM, Heskamp S, Boswinkel M, Peters JPW, Adema GJ, et al. Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models. Clin Transl Radiat Oncol. 2024;49:100875.","journal-title":"Clin Transl Radiat Oncol"},{"key":"9016_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40170-024-00342-6","volume":"12","author":"APM Beerkens","year":"2024","unstructured":"Beerkens APM, Boreel DF, Nathan JA, Neuzil J, Cheng G, Kalyanaraman B, et al. Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging. Cancer Metab. 2024;12:13.","journal-title":"Cancer Metab"},{"key":"9016_CR46","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-05661-6","volume":"614","author":"CR Bartman","year":"2023","unstructured":"Bartman CR, Weilandt DR, Shen Y, Lee WD, Han Y, TeSlaa T, et al. Slow TCA flux and ATP production in primary solid tumours but not metastases. Nature. 2023;614:349\u201357.","journal-title":"Nature"},{"key":"9016_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117\u201320.","journal-title":"Nature"},{"key":"9016_CR48","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, et al. N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell. 2015;161:1388\u201399.","journal-title":"Cell"},{"key":"9016_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49105-3","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Sun Y, Wang Z, Huang X, Tang L, Jiang K, et al. ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression. Nat Commun. 2024;15:4642.","journal-title":"Nat Commun"},{"key":"9016_CR50","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3072","volume":"8","author":"M Ratnadiwakara","year":"2018","unstructured":"Ratnadiwakara M, \u00c4nk\u00f6 ML. mRNA stability assay using transcription inhibition by actinomycin D in mouse pluripotent stem cells. Bio-Protoc. 2018;8:e3072.","journal-title":"Bio-Protoc"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09016-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:47:25Z","timestamp":1788997645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09016-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9016"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09016-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were approved by Institutional Animal Care and Use Committee (IACUC) of the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, and conducted in accordance with the guidelines for the care and use of laboratory animals (approval number: ACUC-A02-2024-014). All methods involving human tissue samples (pathological sections) were performed in accordance with the relevant guidelines and regulations for human study. A written informed consent was obtained from all patients and the study was approved by the PUMCH Institutional Review Board (approval number: I-24PJ2172).","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"788"}}